Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

October 31, 2012

Conditions
Chagas' Disease
Interventions
DRUG

Benznidazole 12,5mg or 100mg

"All 80 subjects recruited into the study will receive treatment with:~\- Benznidazole (Laboratório Farmacêutico do Estado de Pernambuco -LAFEPE - Recife - Brazil; tablet 12.5mg or 100mg), 7.5 mg/Kg/day PO (actual range of 5.5-8.5 mg/Kg/d), divided in two daily doses, for 60 days."

Trial Locations (3)

C1425

Hospital General de Niños Ricardo Gutierrez, Buenos Aires

CP3400

Hospital Público Materno Infantil, Salta

CP4600

"Hospital de Niños Doctor Héctor Quintana", San Salvador de Jujuy

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

LAT Research

OTHER

lead

Drugs for Neglected Diseases

OTHER

NCT01549236 - Population Pharmacokinetics Study of Benznidazole in Children With Chagas'Disease | Biotech Hunter | Biotech Hunter